1 Genetic changes: Relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia

Anastasi, 1991, Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukaemia and resolves the question of origin of relapse after allogeneic bone marrow transplantation, Blood, 77, 1087, 10.1182/blood.V77.5.1087.1087 Anastasi, 1991, Direct correlation of cytogenetic findings with cell morphology using in situ hybridisation: an analysis of suspicious cells in bone marrow specimens of two patients completing therapy for acute lymphoblastic leukaemia, Blood, 77, 2456, 10.1182/blood.V77.11.2456.2456 Aplan, 1990, Disruption of the human SCL locus by ‘illegitimate’ V(D)-J recombinase activity, Science, 250, 1426, 10.1126/science.2255914 Aplan, 1991, Structural characterisation of Sil, a gene frequently disrupted in T-cell acute lymphoblastic leukaemia, Molecular and Cellular Biology, 11, 5462, 10.1128/MCB.11.11.5462 Arkesteijn, 1988, Bivariate flow karoytpes in human Philadelphia-positive chronic myelocytic leukaemia, Blood, 72, 282, 10.1182/blood.V72.1.282.282 Arnold, 1983, Immunoglobulin gene rearrangements as unique clonal markers in human lymphoid neoplasms, New England Journal of Medicine, 309, 1593, 10.1056/NEJM198312293092601 Asou, 1989, Rearrangements of T-cell antigen receptor δ gene in hematologic neoplasms, Blood, 74, 2707, 10.1182/blood.V74.8.2707.2707 D'Auriol, 1989, In vitro amplification of T cell γ gene rearrangements: A new tool for the assessment of minimal residual disease in acute lymphoblastic leukaemias, Leukemia, 3, 155 Barlogie, 1983, Flow cytometry in clinical cancer research, Cancer Research, 43, 3982 Bartram, 1992, Minimal residual disease in ALL, 82, 182 Bartram, 1989, Minimal residual leukaemia in chronic myeloid leukaemia patients after T-cell depleted bone marrow transplantation, Lancet, 1, 1260, 10.1016/S0140-6736(89)92349-0 Bartram, 1992, Detection of minimal residual disease in acute lymphoblastic leukaemia by polymerase chain reactions, Haematology and Blood Transfusion, 34, 171, 10.1007/978-3-642-76591-9_25 Bash, 1993, Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TALI locus: A Pediatric Oncology Group study, Blood, 81, 2110, 10.1182/blood.V81.8.2110.2110 Begley, 1989, Chromosomal translocation in a human leukemic cell line disrupts the T-cell antigen receptor δ-chain diversity region and results in a previously unreported fusion transcript, 86, 2031 Beishuizen, 1991, Detection of minimal residual disease in childhood leukemia with the polymerase chain reaction, New England Journal of Medicine, 324, 772, 10.1056/NEJM199103143241113 Beishuizen, 1991, Multiple rearranged immunoglobulin genes in childhood lymphoblastic leukaemia of precursor B-cell origin, Leukemia, 5, 657 Beishuizen, 1992, Differences in immunoglobulin chain gene rearrangement patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leukaemia at diagnosis, Leukemia, 6, 60 Benz-Boehm, 1990, MRI of the knee region in leukaemic children. Part II. Follow up: responder, non-responder, Pediatric Radiology, 20, 272, 10.1007/BF02019665 Bernard, 1988, Molecular mechanisms of a t(8;14)(q24;q11) translocation juxtaposing c-myc and TcR-α genes in a T-cell leukaemia: involvement of Vα internal heptamer, Oncogene, 2, 195 Bernard, 1990, Two distinct mechanisms for the scl gene activation in the t(1;14) translocation of the T-cell leukaemias, Genes, Chromosomes and Cancer, 1, 194, 10.1002/gcc.2870010303 Bernard, 1991, Two specific deletions and t(1;14) translocation restricted to human T-cell acute leukaemias disrupt the 5′ part of the tal-1 gene, Oncogene, 6, 1477 Billadeau, 1991, Analysis of B lymphoid malignancies using allele-specific polymerase chain reaction. A technique for sequential quantification of residual disease, Blood, 78, 3021, 10.1182/blood.V78.11.3021.3021 Biondi, 1990, High prevalence of T-cell receptor Vd2-(D)-Dd3 or Dd1/2-Dd3 rearrangements in B-precursor acute lymphoblastic leukemias, Blood, 75, 1834, 10.1182/blood.V75.9.1834.1834 Biondi, 1992, Minimal residual disease in childhood acute lymphoblastic leukaemia: analysis of patients in continuous complete remission or with consecutive relapse, Leukemia, 6, 282 Bird, 1988, Continuing rearrangements but absence of somatic hypermutations in immunoglobulin genes of human B cell precursor leukaemia, Journal of Experimental Medicine, 168, 229, 10.1084/jem.168.1.229 Bleyr, 1988, Central nervous system leukemia, Pediatric Clinics of North America, 35, 789, 10.1016/S0031-3955(16)36510-5 Bloomfield, 1986, Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia, Blood, 67, 415, 10.1182/blood.V67.2.415.415 Boehm, 1990, An unusual structure of a putative T cell oncogene which allows production of similar proteins from distinct mRNAs, EMBO Journal, 9, 857, 10.1002/j.1460-2075.1990.tb08183.x Boehm, 1991, The rhombotin family of cysteine-rich LIM domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13, 88, 4367 Boehm, 1991, Developmentally regulated and tissue specific expression of mRNAs encoding the two alternative forms of the LIM domain oncogene rhombotin: evidence for thymic expression, Oncogene, 6, 695 Borella, 1973, Immunological rebound after cessation of long-term chemotherapy in acute leukaemia, Blood, 40, 42, 10.1182/blood.V40.1.42.42 Borkhardt, 1992, Frequency and DNA sequence of tal-1 rearrangement in children with T-cell acute lymphoblastic leukaemia, Annals of Hematology, 64, 305, 10.1007/BF01695477 Bradstock, 1981, Diagnosis of meningeal involvement in patients with acute lymphoblastic leukaemia: immunofluorescence for terminal transferase, Cancer, 47, 2478, 10.1002/1097-0142(19810515)47:10<2478::AID-CNCR2820471027>3.0.CO;2-A Breard, 1989, Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukaemia after complete remission, Bulletin of the Society of Science, Grand Duchy of Luxemburg, 126, 47 Bregni, 1989, Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis, Journal of Clinical Oncology, 7, 338, 10.1200/JCO.1989.7.3.338 Breit, 1993, Site-specific deletions involving the tal-1, silgenes are restricted to cells of the T cell receptor α/β lineage T cell receptor δ gene deletion mechanism affects multiple genes, Journal of Experimental Medicine, 177, 965, 10.1084/jem.177.4.965 Brisco, 1990, Development of a highly sensitive assay, based on the polymerase chain reaction for rare B-lymphocyte clones in a polyclonal population, British Journal of Haematology, 75, 163, 10.1111/j.1365-2141.1990.tb02643.x Brisco, 1991, Detection and quantification of neoplastic cells in acute lymphoblastic leukaemia by use of polymerase chain reaction, British Journal of Haematology, 79, 211, 10.1111/j.1365-2141.1991.tb04524.x Brisco, 1994, Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction, Lancet, 343, 196, 10.1016/S0140-6736(94)90988-1 Browett, 1989, Analysis of ras gene mutation and methylation state in human leukaemias, Oncogene, 4, 1029 Brown, 1990, Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukaemia, EMBO Journal, 9, 3343, 10.1002/j.1460-2075.1990.tb07535.x Burnett, 1991, The Lck gene is involved in the t(1;7)(p34;q34) in the T-cell acute lymphoblastic derived cell line HSB-2, Genes, Chromosomes and Cancer, 3, 461, 10.1002/gcc.2870030608 Bunin, 1986, Gene rearrangements as clonal markers at diagnosis and relapse in childhood acute leukemia, Blood, 68, 196a Bunin, 1990, Alterations in immunoglobulin or T cell receptor gene rearrangement at relapse: involvement of 11q23 and changes in immunophenotype, Leukemia, 4, 727 Campana, 1990, The immunologic detection of minimal residual disease in acute leukaemia, Blood, 76, 163, 10.1182/blood.V76.1.163.163 Campana, 1990, Immunophenotyping in haematological diagnosis, Baillières Clinical Haematology, 3, 889, 10.1016/S0950-3536(05)80140-4 Campana, 1990, The detection of residual disease in acute lymphoblastic leukaemia cells in immunologic methods and polymerase chain reaction: a comparative study, Leukemia, 4, 609 Campana, 1991, Review. The definition of remission in acute leukaemia with immunologic techniques, Bone Marrow Transplantation, 8, 429 Carter, 1991, Characterisation of immunoglobulin genes from an acute lymphocytic leukemia with four rearrangements, Leukemia, 5, 668 Chen, 1991, Breakpoint clustering in t(4;11)(q21;q23) acute leukaemia, Blood, 78, 2498, 10.1182/blood.V78.10.2498.2498 Chen, 1990, The tal gene undergoes chromosome translocation in T cell leukaemia and potentially encodes helix-loop-helix protein, EMBO Journal, 9, 415, 10.1002/j.1460-2075.1990.tb08126.x Cheng, 1990, Frequent mutation in the p53 tumour suppressor gene in human T cell lines, Molecular and Cellular Biology, 10, 5502, 10.1128/MCB.10.10.5502 Cleary, 1991, Oncogenic conversion of transcription factors by chromosomal translocations. Minireview, Cell, 66, 619, 10.1016/0092-8674(91)90105-8 Cole-Sinclair, 1992, The use of a polymerase chain reaction (PCR) based immunoglobulin ‘gene fingerprinting’ technique to detect minimal residual disease (MRD) in acute lymphoblastic leukaemia (ALL), Blood, 80, 105a Cole-Sinclair, 1993, Minimal residual disease in acute lymphoblastic leukaemia-PCR analysis of immunoglobulin gene rearrangements, Leukemia and Lymphoma, 11, 49, 10.3109/10428199309064262 Crescenzi, 1988, Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease, 85, 4869 Crist, 1990, Poor prognosis of children with pre-B acute lymphoblastic leukaemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study, Blood, 76, 117, 10.1182/blood.V76.1.117.117 Croce, 1985, Role of chromosome translocation in human neoplasia. Minireview, Cell, 49, 155, 10.1016/0092-8674(87)90552-6 Cross, 1992, The use of PCR to detect MRD after BMT for CML. Association with GVHD and relapse, Blood, 80, 300a Deane, 1993, Detection of minimal residual disease in acute lymphoblastic leukaemia, 135 Deane, 1990, Detection of immunoglobulin gene rearrangement in B lymphoid malignancies by polymerase chain reaction gene amplification, British Journal of Haematology, 74, 251, 10.1111/j.1365-2141.1990.tb02579.x Deane, 1991, Immunoglobulin gene ‘fingerprinting’: an approach to analysis of B lymphoid clonality in lymphoproliferative disorders, British Journal of Haematology, 77, 274, 10.1111/j.1365-2141.1991.tb08570.x Deane, 1991, Detection of immunoglobulin gene rearrangement in B cell neoplasias by polymerase chain reaction/gene amplification, Leukemia and Lymphoma, 5, 9, 10.3109/10428199109068100 Deane, 1991, An improved method for the detection of B-lymphoid clonality by polymerase chain reaction, Leukemia, 5, 726 Deane, 1991, Immunoglobulin heavy chain gene fingerprinting reveals widespread oligoclonality in B-lineage acute lymphoblastic leukaemia, Leukemia, 5, 832 Deane, 1992, Detection of minimal residual disease in B lineage leukaemia by immunoglobulin gene fingerprinting, Haematology and Blood Transfusion, 34, 178, 10.1007/978-3-642-76591-9_26 Devarj, 1994, E2A-HLF fusion DNA and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia, Leukemia, 8 Diaz, 1990, Deletion of interferon genes in acute lymphoblastic leukemia, New England Journal of Medicine, 322, 77, 10.1056/NEJM199001113220202 Don, 1991, ‘Touchdown’ PCR to circumvent spurious priming during gene amplification, Nucleic Acids Research, 19, 4008, 10.1093/nar/19.14.4008 Drach, 1991, Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemia, British Journal of Haematology, 77, 37, 10.1111/j.1365-2141.1991.tb07945.x Dyer, 1989, T-cell receptor δ/α rearrangements in lymphoid neoplasms, Blood, 74, 1073, 10.1182/blood.V74.3.1073.1073 Ellisen, 1991, TAN-1, the human homolog of the Drosophila notch gene is broken by chromosomal translocations in T lymphoblastic neoplasms, Cell, 66, 649, 10.1016/0092-8674(91)90111-B Estrov, 1986, Detection of residual acute lymphoblastic leukaemia cells in cultures of bone marrow obtained during remission, New England Journal of Medicine, 315, 538, 10.1056/NEJM198608283150902 Estrov, 1992, Detection of residual acute lymphoblastic leukaemia (ALL) progenitor cells during remission using a clonogenic assay and polymerase chain reaction (PCR), Blood, 80, 284a Farr, 1988, Analysis of ras mutations in acute myeloid leukaemia by polymerase chain reaction and oligonucleotide probes, 85, 1629 Felix, 1991, Characterisation of acute lymphoblastic leukaemia in childhood by immunoglobulin gene patterns. Review, Leukemia, 5, 1015 Felix, 1987, T-cell receptor α-, β-, and γ-genes in T cell and pre-B cell acute lymphoblastic leukemia, Journal of Clinical Investigation, 80, 545, 10.1172/JCI113103 Fey, 1987, Molecular diagnosis of haematological disorders using DNA from stored bone marrow slides, British Journal of Haematology, 67, 489, 10.1111/j.1365-2141.1987.tb06174.x Foa, 1984, Different stages of B cell differentiation in non-T acute lymphoblastic leukemia, Journal of Clinical Investigation, 74, 1756, 10.1172/JCI111594 Foroni, 1989, Rearrangement of the T-cell receptor δ genes in human T-cell leukemias, Blood, 73, 559, 10.1182/blood.V73.2.559.559 Foroni, 1990, Immunoglobulin and T-cell receptor gene analysis for the investigation of lymphoproliferative disorders, 339 Foroni, 1992, The Rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development, Journal of Molecular Biology, 226, 747, 10.1016/0022-2836(92)90630-3 Frankel, 1992, Cytogenetics is the most important prognostic factor in adult acute leukaemia (ALL), Blood, 80, 257a Gaidano, 1991, p53 mutations in human lymphoid malignancies: Association with Burkitt's lymphoma and chronic lymphocytic leukemia, 88, 5413 Gehly, 1992, Diagnosis of miminal residual disease in bone marrow transplant patients, Clinical and Laboratory Medicine, 12, 129 Gehly, 1991, Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosomepositive acute lymphoblastic leukemia, Blood, 78, 458, 10.1182/blood.V78.2.458.bloodjournal782458 Goblet, 1989, One-step amplification of transcripts in total RNA using the polymerase chain reaction, Nucleic Acids Research, 17, 2144, 10.1093/nar/17.5.2144 Gore, 1990, Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry, Journal of Immunological Methods, 132, 275, 10.1016/0022-1759(90)90039-X Gray, 1990, Analytical approaches to detection and characterisation and characterisation of disease linked in chromosome aberrations, Bone Marrow Transplantation, 6, 14 Gray, 1991, Molecular cytometry applied to detection and characterisation of disease-linked chromosome aberrations, Baillière's Clinical Haematology, 4, 683, 10.1016/S0950-3536(09)90007-5 Green, 1992, Transcription factors, translocations and haematological malignancies, Blood Reviews, 6, 118, 10.1016/0268-960X(92)90013-G Grimaldi, 1989, The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene, Blood, 73, 2081, 10.1182/blood.V73.8.2081.2081 Groffen, 1984, Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22, Cell, 36, 93, 10.1016/0092-8674(84)90077-1 Gu, 1992, The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene, Cell, 71, 701, 10.1016/0092-8674(92)90603-A Hagenbeek, 1992, Minimal residual disease in leukaemia: state of the art 1991, Leukemia, 6, 12 Hagenbeek, 1991, Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML), Baillière's Clinical Haematology, 4, 609, 10.1016/S0950-3536(09)90004-X Hann, 1977, Discrepancy in bone marrow aspirations in acute leukaemia in relapse, Lancet, 1, 1215, 10.1016/S0140-6736(77)92766-0 Hansen-Hagge, 1989, Detection of minimal residual disease in acute lymphoblastic leukaemia by in vitro amplification of rearranged T-cell receptor δ chain sequences, Blood, 74, 1762, 10.1182/blood.V74.5.1762.1762 Hatano, 1991, Deregulation of a homeobox gene Hox-11, by the t(10;14) in T cell leukemia, Science, 253, 79, 10.1126/science.1676542 Heerema, 1990, Cytogenetic abnormalities and molecular markers of acute lymphoblastic leukemia, Hematology and Oncology Clinics of North America, 4, 795, 10.1016/S0889-8588(18)30468-4 Heisterkamp, 1985, Structural organisation of the bcr gene and its role in Ph1 translocation, Nature, 315, 758, 10.1038/315758a0 Hittelman, 1988, Detection of leukemic clone in vivo by premature chromosomal condensation, Blood, 72, 1950, 10.1182/blood.V72.6.1950.1950 Hittelman, 1990, Premature chromosomal condensation in the study of minimal residual disease, Bone Marrow Transplantation, 6, 9 Hoelzer, 1990, Change in treatment strategies for acute lymphoblastic leukemia (ALL) according to prognostic factors and minimal residual disease, Bone Marrow Transplantation, 6, 66 Hollstein, 1991, p53 mutations in human cancer, Science, 253, 49, 10.1126/science.1905840 Hooijkaas, 1989, Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukemia: a 5-year follow-up study in 113 children with TdT-positive leukaemia or non-Hodgkin's lymphoma, Blood, 74, 416, 10.1182/blood.V74.1.416.416 Hughes, 1991, Clinical value of PCR in diagnosis and follow-up of leukemia and lymphoma: Report of the Third Workshop of the Molecular Biology/BMT Study Group, Leukemia, 5, 448 Hughes, 1991, Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse, Blood, 77, 874, 10.1182/blood.V77.4.874.874 Hunger, 1992, The t(17;19) derived chimeric protein E2A-HLF displays dominant negative transcriptional regulatory proteins, Blood, 80, 153a Hunger, 1991, The t(1;19)(q23;p13) results in consistent fusion of E2A and PBXI coding sequences in acute lymphoblastic leukaemia, Blood, 77, 687, 10.1182/blood.V77.4.687.687 Hunger, 1992, Hfl a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia, Genes and Development, 6, 1608, 10.1101/gad.6.9.1608 Imamura, 1991, Detection of minimal residual disease in acute lymphoblastic leukemia in flow cytometry with monoclonal antibodies, American Journal of Hematology, 38, 332, 10.1002/ajh.2830380416 Inaba, 1992, Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia, Science, 257, 531, 10.1126/science.1386162 Izaguire, 1981, A colony assay for the blast cell progenitors in non-B non-T (common) acute lymphoblastic leukemia, Blood, 66, 439 Izraeli, 1991, Multiprimer-PCR screening of genetic abnormalities in acute lymphoblastic leukemia, British Journal of Haematology, 79, 645, 10.1111/j.1365-2141.1991.tb08095.x Jacobs, 1977, Discrepant bone marrow aspiration in leukaemia, Lancet, 2, 355, 10.1016/S0140-6736(77)91515-X Jones, 1987, Bone marrow in leukaemia, aplastic leukaemia: MR imaging before, during, and after treatment, Radiology, 162, 701, 10.1148/radiology.162.3.3544034 Jonsson, 1990, Detection of minimal residual disease in acute lymphoblastic leukaemia using immunoglobulin hypervariable region specific oligonucleotide probes, Blood, 76, 2072, 10.1182/blood.V76.10.2072.2072 Jonsson, 1991, Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia, Journal of Clinical Investigation, 87, 2029, 10.1172/JCI115232 Kabat, 1987, Sequences of Proteins of Immunological Interest Kagan, 1990, Detection of minimal residual disease in leukaemic patients with the t(10;14)(q24;q11) chromosomal translocations, Cancer Research, 50, 5240 Kamps, 1990, A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL, Cell, 60, 547, 10.1016/0092-8674(90)90658-2 Katz, 1989, The use of DNA probes to monitor minimal residual disease in childhood acute leukaemia, British Journal of Haematology, 73, 173, 10.1111/j.1365-2141.1989.tb00249.x Kawasaki, 1988, Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplification in vitro, 85, 5698 Kearney, 1992, Chromosome 11q23 translocations in both infant and adult acute leukemias are detected by in situ hybridisation with a yeast artificial chromosome, Blood, 80, 1659, 10.1182/blood.V80.7.1659.1659 Kennedy, 1991, Hox 11, a homeobox-containing T-cell oncogene on human chromosome 10q24, 88, 8900 Kitchingman, 1993, Immunoglobulin heavy chain gene Vh-D junctional diversity at diagnosis in patients with acute lymphoblastic leukemia, Blood, 81, 775, 10.1182/blood.V81.3.775.775 Kitchingman, 1986, Biologic and prognostic significance of the presence of more than two μ heavy-chain genes in childhood acute lymphoblastic leukemia of B precursor cell origin, Blood, 67, 698, 10.1182/blood.V67.3.698.698 Klein, 1983, Specific chromosomal translocations and the genesis of B-cell derived tumours in mice and man, Cell, 32, 311, 10.1016/0092-8674(83)90449-X Koch, 1991, A strategy for direct sequence analysis of junctional DNA sequences of T-cell receptor gamma and immunoglobulin heavy chain rearrangements, Blood, 78, 168a Komp, 1983, Frequency of bone marrow aspirates to monitor lymphoblastic leukemia in childhood, Journal of Pediatrics, 102, 395, 10.1016/S0022-3476(83)80658-1 Korsmeyer, 1987, Antigen receptor genes as molecular markers of lymphoid neoplasms, Journal of Clinical Investigation, 79, 1291, 10.1172/JCI112951 Kwok, 1989, Avoiding false positives with PCR, Nature, 339, 237, 10.1038/339237a0 Laing, 1992, An intronic mutation in the WT1 gene is associated with childhood ALL, Blood, 80, 440a Lange, 1990, Detection of minimal residual leukemia in lymphoblastic leukemia, Hematology and Oncology Clinics of North America, 4, 895 Le Beau, 1993, Detecting genetic changes in human tumour cells: have scientists ‘gone fishing?’, Blood, 81, 1979, 10.1182/blood.V81.8.1979.1979 Leder, 1982, The genetics of antibody diversity, Scientific American, 246, 102, 10.1038/scientificamerican0582-102 Loiseau, 1989, Rearrangements of the T receptor δ gene in T acute lymphoblastic leukaemia cells are distinct from those occurring in B lineage acute lymphoblastic leukaemia and preferentially involve one Vδ gene segment, Journal of Immunology, 142, 3305 Look, 1991, Pathology of the acute lymphoid leukaemia cell, 763 Lowenberg, 1991, Practical aspects and diagnostic significance of in vitro manipulation of progenitors in human acute myeloid and lymphoid leukaemia, Baillière's Clinical Haematology, 4, 637, 10.1016/S0950-3536(09)90005-1 Lowenberg, 1982, A method for cloning T lymphocytic precursors in agar, American Journal of Hematology, 6, 35, 10.1002/ajh.2830060106 Lowenberg, 1980, PHA-induced colony formation in acute non-lymphocytic and chronic myeloid leukemia, Leukemia Research, 4, 143, 10.1016/0145-2126(80)90053-3 Lubert, 1990, N-ras gene point mutations in childhood acute lymphoblastic leukemia correlate with a poor prognosis, Blood, 75, 1163, 10.1182/blood.V75.5.1163.1163 Macintyre, 1990, Use of oligonucleotide probes directed against the T cell antigen receptor gamma delta variable-(diversity) joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukaemias, Journal of Clinical Investigation, 86, 2125, 10.1172/JCI114951 McGuire, 1989, The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukaemia cell line activates multiple transcripts, including ttg-1, a gene encoding potential zinc finger protein, Molecular and Cellular Biology, 9, 2124, 10.1128/MCB.9.5.2124 Marshall, 1991, Tumour suppressor genes, Cell, 64, 313, 10.1016/0092-8674(91)90641-B Martens, 1987, Nonhomogeneous distribution of leukemia in the bone marrow during minimal residual disease, Blood, 70, 1073, 10.1182/blood.V70.4.1073.1073 Maurer, 1991, Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction, Lancet, 337, 1055, 10.1016/0140-6736(91)91706-Z Meeker, 1990, Activation of the interleukin-3 gene by chromosome translocation in acute lymphoblastic leukemia with eosinophilia, Blood, 76, 285, 10.1182/blood.V76.2.285.285 Mellentin, 1989, Lyl-1, a novel gene altered by the chromosomal translocation in T cell leukemia codes for a protein with a helix-loop-helix DNA binding motif, Cell, 58, 77, 10.1016/0092-8674(89)90404-2 Mellentin, 1990, Molecular analysis of the t(1;19) breakpoint cluster region in pre-B cell acute lymphoblastic leukemia, Genes, Chromosomes and Cancer, 2, 239, 10.1002/gcc.2870020313 Melo, 1993, The ABL-BCR fusion gene is expressed in chronic myeloid leukemia, Blood, 81, 158, 10.1182/blood.V81.1.158.158 Melo, 1993, Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia, Blood, 81, 2488, 10.1182/blood.V81.10.2488.2488 Mengle-Gaw, 1987, Human T-cell tumours containing chromosome 14 inversion or translocation with breakpoints proximal to immunoglobulin joining region at 14q32, EMBO Journal, 6, 2273, 10.1002/j.1460-2075.1987.tb02501.x Middleton, 1991, Alpha interferon gene deletions in adults, children and infants with acute lymphoblastic leukaemia, Leukemia, 5, 680 Miller, 1991, Correlation of occult clonogenic leukaemia drug sensitivity with relapse after autologous bone marrow transplantation, Blood, 78, 1125, 10.1182/blood.V78.4.1125.1125 Miller, 1990, The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group, Journal of Clinical Oncology, 8, 57, 10.1200/JCO.1990.8.1.57 Mills, 1992, Amplification and sequencing of genomic breakpoints located within the M-bcr region by vectorette-mediated polymerase chain reaction, Leukemia, 6, 481 Minden, 1986, The structure of the T-cell antigen receptor genes in normal and malignant T cells, Blood, 68, 327, 10.1182/blood.V68.2.327.327 Mitelman, 1990, Report of the committee on chromosome changes in neoplasia, Cytogenetics and Cell Genetics, 55, 358, 10.1159/000133022 Miyamura, 1990, Prediction of clinical relapse after bone marrow transplantation by PCR for Philadelphia-positive acute lymphoblastic leukaemia, Lancet, 336, 890, 10.1016/0140-6736(90)92414-D Miyamura, 1992, Detection of Philadelphia chromosomepositive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation, Blood, 79, 1366, 10.1182/blood.V79.5.1366.1366 Moore, 1986, Bone marrow in children with acute lymphocytic leukaemia: MR relaxation times, Radiology, 160, 237, 10.1148/radiology.160.1.3459212 Morgan, 1992, Breakpoints at 11q23 in infant leukemias with t(11;19)(q23;p13) are clustered, Blood, 80, 2172, 10.1182/blood.V80.9.2172.2172 Nadler, 1984, B cell origin of non-T-cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation, Journal of Clinical Investigation, 74, 332, 10.1172/JCI111428 Nakajima-Iijima, 1985, Molecular structure of the human cytoplasmic β-actin gene: intraspecies homology of sequences in the introns, 82, 6133 Neale, 1991, Detection of minimal residual disease in T-cell lymphoblastic leukemia using polymerase chain reaction predicts impending relapse, Blood, 78, 739, 10.1182/blood.V78.3.739.739 Neri, 1988, Analysis of ras oncogene mutations in human lymphoid malignancies, 85, 9268 Nichols, 1992, Transcription factors, translocations, and leukemia, Blood, 80, 2953, 10.1182/blood.V80.12.2953.2953 Nizet, 1991, Follow-up of residual disease (MRD) in B lineage acute lymphoblastic leukaemias using a simplified PCR strategy: evolution of MRD rather than detection is correlated with clinical outcome, British Journal of Haematology, 79, 205, 10.1111/j.1365-2141.1991.tb04523.x Nourse, 1990, Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor, Cell, 60, 535, 10.1016/0092-8674(90)90657-Z Nowell, 1987, Molecular monitoring of pre-B acute lymphocytic leukaemia, Journal of Clinical Oncology, 5, 692, 10.1200/JCO.1987.5.5.692 Odom, 1990, Significance of blasts in low-cell-count cerebrospinal fluid specimens from children with acute lymphoblastic leukaemia, Cancer, 66, 1748, 10.1002/1097-0142(19901015)66:8<1748::AID-CNCR2820660818>3.0.CO;2-E Oettinger, 1990, RAG-1 and RAG-2 adjacent genes that synergistically activate V(D)J recombination, Science, 248, 1517, 10.1126/science.2360047 Pakkala, 1991, DNA fingerprinting in the detection of residual disease in acute leukemia, Leukemia, 5, 437 Parada, 1984, Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation, Nature, 312, 649, 10.1038/312649a0 Persico, 1981, c-DNA sequences of human glucose 6-phosphate dehydrogenase cloned in pBR322, Nature, 294, 778, 10.1038/294778a0 Pittaluga, 1992, Detection of the chimaeric mRNA of bcr-abl by in situ hybridisation on K562 cell line suspension, Blood, 80, 33a Poddighe, 1991, Interphase cytogenetics of haematologic cancer: comparison of classical karyotyping and in situ hybridisation using a panel of eleven chromosome-specific probes, Cancer Research, 51, 1959 Porfiri, 1993, DCC tumour suppressor gene is inactivated in hematologic malignancies showing monosomy 18, Blood, 81, 2696, 10.1182/blood.V81.10.2696.2696 Potter, 1992, Detection of minimal residual disease in acute lymphoblastic leukaemia, Blood Reviews, 6, 68, 10.1016/0268-960X(92)90009-F Potter, 1992, Detection of clonality in childhood B-lineage acute lymphoblastic leukaemia by polymerase chain reaction, Leukemia, 6, 289 Potter, 1993, Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meetings report and review, Leukemia, 7, 1302 Potter, 1993, The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia, British Journal of Haematology, 83, 412, 10.1111/j.1365-2141.1993.tb04665.x Pui, 1985, Effective testicular biopsy during chemotherapy for childhood leukaemia, Lancet, ii, 310 Pui, 1986, Shift in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia, Blood, 68, 1306, 10.1182/blood.V68.6.1306.1306 Pui, 1990, Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia, Blood, 76, 1449, 10.1182/blood.V76.8.1449.1449 Rabbitts, 1991, Translocations, master genes and differences between the origins of acute and chronic leukaemias, Cell, 67, 641, 10.1016/0092-8674(91)90057-6 Rabbitts, 1991, Structural and functional chimerism results from chromosomal translocations in lymphoid tumours, Advances in Immunology, 50, 119, 10.1016/S0065-2776(08)60824-X Raghavachar, 1987, Analyses of phenotype and genotype in acute lymphoblastic leukemias at first presentation and relapse, Blood, 70, 1079, 10.1182/blood.V70.4.1079.1079 Raghavachar, 1988, More than two immunoglobulin heavy chain J region genes in the majority of infant leukaemias, European Journal of Pediatrics, 147, 503, 10.1007/BF00441975 Rhoads, 1986, Primary structure of human ribosomal protein S14 and the gene that encodes it, Molecular and Cellular Biology, 6, 2774, 10.1128/MCB.6.8.2774 Rogers, 1984, Yield of unpredicted bone marrow relapse diagnosed by routine marrow aspiration in children with acute lymphoblastic leukaemia, Lancet, i, 1320, 10.1016/S0140-6736(84)91819-1 Rovera, 1991, Detection of minimal residual disease in childhood leukemia by the polymerase chain reaction, New England Journal of Medicine, 324, 774 Rowley, 1982, Identification of the constant chromosome region involved in human haematologic malignant disease, Science, 216, 749, 10.1126/science.7079737 Royer-Pokora, 1991, TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11), Oncogene, 6, 1887 Russo, 1988, Molecular analysis of a t(7;14)(q35;q32) chromosome translocation in a T cell leukaemia of a patient with ataxia telangiectasia, Cell, 53, 137, 10.1016/0092-8674(88)90495-3 Sacchi, 1992, Down's syndrome and chromosome 21 abnormalities in leukaemia, Baillière's Clinical Haematology, 5, 815, 10.1016/S0950-3536(11)80047-8 Saiki, 1985, Enzymatic amplification of β-globin genomic sequences and restriction site analysis of sickle cell anaemia, Science, 230, 1350, 10.1126/science.2999980 Saiki, 1988, Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase, Science, 239, 487, 10.1126/science.2448875 Sarkar, 1990, Shedding light on PCR contamination, Nature, 343, 27, 10.1038/343027a0 Sather, 1986, Statistical evaluation of prognostic factors in ALL and treatment results, Medical and Pediatric Oncology, 14, 158, 10.1002/mpo.2950140310 Schatz, 1989, The V(D)J recombination activating gene, RAG-1, Cell, 59, 1035, 10.1016/0092-8674(89)90760-5 Secker-Walker, 1978, Prognostic implication of chromosomal findings in acute lymphoblastic leukaemia at diagnosis, British Medical Journal, 2, 1529, 10.1136/bmj.2.6151.1529 Secker-Walker, 1991, Philadelphia-positive acute lymphoblastic leukemia in adults: age distribution. BCR breakpoint and prognostic significance, Leukemia, 5, 196 Seibel, 1989, Tumour detection through the use of immunoglobulin gene rearrangements combined with tissue in situ hybridisation, Blood, 74, 1791, 10.1182/blood.V74.5.1791.1791 Senn, 1988, Relapse cell population differs from acute onset clone as shown by absence of the initial activated N-ras oncogene in a patient with acute myelogenous leukaemia, Blood, 72, 931, 10.1182/blood.V72.3.931.bloodjournal723931 Shiramizu, 1990, Localisation of breakpoints by polymerase chain reactions in Burkitt's lymphoma with 8;14 translocations, Blood, 75, 1848, 10.1182/blood.V75.9.1848.1848 Slavin, 1991, Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation, Baillière's Clinical Haematology, 4, 715, 10.1016/S0950-3536(09)90009-9 Smith, 1989, Phenotypic heterogeneity of TDT+ cells in the blood and bone marrow: implications for the surveillance of residual leukemia, Blood, 74, 312, 10.1182/blood.V74.1.312.312 Steward, 1992, Third complementarity determining region (CDR-III) sequence analysis in childhood B-lineage acute lymphoblastic leukemia: implications for the design of oligonucleotides for use in monitoring minimal residual disease, Leukemia, 6, 1213 Sugimoto, 1991, Mutations of the p53 gene in lymphoid leukemia, Blood, 77, 1153, 10.1182/blood.V77.6.1153.1153 Suijkerbuijk, 1992, Fluorescent in situ identification of human marker chromosomes using flow sorting and Alu-element-medicated PCR, Genomics, 3, 355, 10.1016/0888-7543(92)90253-O Tasheva, 1993, Possible new genetic marker for human lymphoid leukemias as detected by ribosomal protein S14 cDNA, Leukemia, 7, 318 Taylor, 1991, The molecular genetic analysis of gene rearrangements in acute lymphoblastic leukaemia, Baillière's Clinical Haematology, 4, 695, 10.1016/S0950-3536(09)90008-7 Tawa, 1985, Rearrangement of the T cell receptor beta-chain gene in non-T-cell non B-cell acute lymphoblastic leukemia of childhood, New England Journal of Medicine, 313, 1033, 10.1056/NEJM198510243131701 Terada, 1990, Alteration of N-ras mutation after relapse in acute lymphoblastic leukemia, Blood, 75, 453, 10.1182/blood.V75.2.453.453 Thompson, 1992, Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantation, Blood, 79, 1629, 10.1182/blood.V79.6.1629.1629 Tkachuk, 1990, Detection of the BCR-ABL fusion in chronic myelogenous leukaemia by in situ hybridisation, Science, 250, 559, 10.1126/science.2237408 Tkachuk, 1992, Involvement of a homolog of Drosophila trithorax gene by 11q23 chromosomal translocation in acute leukemias, Cell, 71, 691, 10.1016/0092-8674(92)90602-9 Trainor, 1990, Monoclonality in B-lymphoproliferative disorders detected at the DNA level, Blood, 75, 2220, 10.1182/blood.V75.11.2220.2220 Tsursawa, 1989, Flow cytometric evidence for minimal residual disease and cytological heterogeneities in acute lymphoblastic leukemia with severe hypodiploidy, American Journal of Hematology, 32, 42, 10.1002/ajh.2830320109 Tycko, 1990, Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model, Cancer Cells, 2, 1 Tycko, 1989, Polymerase chain reaction amplification of rearranged antigen receptor genes using junction-specific oligonucleotides: possible applications for detection of minimal residual disease in acute lymphoblastic leukaemia, Cancer Cells, 7, 47 Tycko, 1992, Changing antigen receptor genes rearrangements in a case of early pre-B cell leukemia: evidence for a tumour progenitor cell with stem cell features and implications for monitoring residual disease, Blood, 79, 481, 10.1182/blood.V79.2.481.481 Van Bekkum, 1984, Reflection on the detection and treatment of leukaemia, 385 Van der Plas, 1992, Prognostic significance of karyotype at diagnosis in childhood acute lymphoblastic leukaemia, Leukemia, 6, 176 Van Dongen, 1991, Analysis of T immunoglobulin and T cell receptor genes. Part I: basic and technical aspects, Clinica Chimica Acta, 198, 1, 10.1016/0009-8981(91)90246-9 Van Dongen, 1991, Analysis of immunoglobulin and T cell receptor genes. Part II: possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders, Clinica Chimica Acta, 198, 93, 10.1016/0009-8981(91)90247-A Van Dongen, 1992, Detection of minimal residual disease in acute leukaemia by immunological marker analysis and polymerase chain reaction, Leukemia, 6, 47 Veelken, 1991, Sensitive detection of clonal antigen receptor gene rearrangements for diagnosis: monitoring of lymphoid neoplasms by a polymerase chain reaction-mediated ribonuclease protection assay, Blood, 78, 1318, 10.1182/blood.V78.5.1318.1318 Waldman, 1987, The arrangement of immunoglobulin and T-cell receptor genes in human lymphoproliferative disorders, Advances in Immunology, 40, 247, 10.1016/S0065-2776(08)60241-2 Wasserman, 1992, Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukaemia, Journal of Clinical Oncology, 10, 1878, 10.1200/JCO.1992.10.12.1879 Wasserman, 1992, VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia, Blood, 79, 223, 10.1182/blood.V79.1.223.223 Wessman, 1989, In situ hybridisation using a Y-specific probe—a sensitive method for distinguishing male recipient cells from female donor cells in bone marrow transplantation, Bone Marrow Transplantation, 4, 283 Williams, 1984, A direct bone marrow chromosome technique for acute lymphoblastic leukaemia, Cancer, Genetics and Cytogentics, 13, 239, 10.1016/0165-4608(84)90046-3 Wright, 1987, Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukaemia, Journal of Clinical Oncology, 5, 735, 10.1200/JCO.1987.5.5.735 Xia, 1991, Tal-2, a helix-loop-helix gene activated by the t(7;9)(q34;q32) translocation in human T-cell leukemia, 88, 11416 Yamada, 1989, Detection of minimal disease in hematopoietic malignancies of B-cell lineage by using third-complementarity-determining region (CDR-III)-Specific probes, 86, 5123 Yamada, 1990, Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemia cells during the first 18 months of treatment, New England Journal of Medicine, 323, 448, 10.1056/NEJM199008163230705 Yokota, 1991, T cell receptor δ gene recombination in common acute lymphoblastic leukemia: preferential usage of Vδ2 and frequent involvement of the Jα cluster, Blood, 77, 141, 10.1182/blood.V77.1.141.141 Yokota, 1991, Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients, Blood, 77, 331, 10.1182/blood.V77.2.331.331 Young, 1991, Chromosome analysis sorting, 145 Yunis, 1986, Prognostic significance of chromosomal abnormalities in acute leukaemias and myeloproliferative syndromes, Clinics in Haematology, 15, 597, 10.1016/S0308-2261(18)30004-3 Zehnbauer, 1986, Immunoglobulin gene rearrangements in remission bone marrow specimens from patients with acute lymphoblastic leukemia, Blood, 67, 835, 10.1182/blood.V67.3.835.835 Zhang, 1990, Significance of FMC-DNA measurement in detecting minimal residual disease in leukemia, New England Journal of Medicine, 103, 826